TOP NEWS UPDATES

Covaxin effective against Delta Plus variant of Covid-19: ICMR Study

ICMR reveals that Covaxin is effective against the Delta Plus variant of COVID 19. New Delhi , india, August 2: A recent study by the Indian Council of Medical Research reveals that Bharat Biotech’s Covaxin is effective against the rampant Delta Plus variant of COVID-19. Covaxin was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) National Institute of Virology (NIV). Earlier, Bharat Biotech had said that Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant. The efficacy analysis demonstrated Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases while safety analysis showed adverse events reported were similar to placebo, with 12 per cent of subjects experiencing commonly known side effects and less than 0. 5 per cent feeling serious adverse events. The efficacy data demonstrated…